Generation Bio (GBIO) Operating Leases (2021 - 2025)
Historic Operating Leases for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $19.7 million.
- Generation Bio's Operating Leases fell 7620.69% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year decrease of 7620.69%. This contributed to the annual value of $80.6 million for FY2024, which is 1027.02% down from last year.
- According to the latest figures from Q3 2025, Generation Bio's Operating Leases is $19.7 million, which was down 7620.69% from $75.6 million recorded in Q2 2025.
- In the past 5 years, Generation Bio's Operating Leases registered a high of $89.8 million during Q4 2023, and its lowest value of $19.7 million during Q3 2025.
- Over the past 5 years, Generation Bio's median Operating Leases value was $75.9 million (recorded in 2022), while the average stood at $70.0 million.
- Per our database at Business Quant, Generation Bio's Operating Leases soared by 8132.67% in 2022 and then tumbled by 7620.69% in 2025.
- Over the past 5 years, Generation Bio's Operating Leases (Quarter) stood at $76.2 million in 2021, then fell by 2.09% to $74.6 million in 2022, then grew by 20.31% to $89.8 million in 2023, then dropped by 10.27% to $80.6 million in 2024, then plummeted by 75.49% to $19.7 million in 2025.
- Its last three reported values are $19.7 million in Q3 2025, $75.6 million for Q2 2025, and $78.1 million during Q1 2025.